EE04870B1 - Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid - Google Patents

Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid

Info

Publication number
EE04870B1
EE04870B1 EEP199900578A EEP9900578A EE04870B1 EE 04870 B1 EE04870 B1 EE 04870B1 EE P199900578 A EEP199900578 A EE P199900578A EE P9900578 A EEP9900578 A EE P9900578A EE 04870 B1 EE04870 B1 EE 04870B1
Authority
EE
Estonia
Prior art keywords
tisoxanide
nitazoxanide
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
EEP199900578A
Other languages
English (en)
Estonian (et)
Inventor
Rossignol Jean-Fran�ois
Original Assignee
Romark Laboratories, L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04870(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Laboratories, L.C. filed Critical Romark Laboratories, L.C.
Publication of EE9900578A publication Critical patent/EE9900578A/xx
Publication of EE04870B1 publication Critical patent/EE04870B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900578A 1997-05-07 1998-05-06 Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid EE04870B1 (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (fr) 1997-05-07 1998-05-06 Compositions pharmaceutiques de tizoxanide et de nitazoxanide

Publications (2)

Publication Number Publication Date
EE9900578A EE9900578A (et) 2000-08-15
EE04870B1 true EE04870B1 (et) 2007-08-15

Family

ID=27420362

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900578A EE04870B1 (et) 1997-05-07 1998-05-06 Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid

Country Status (35)

Country Link
EP (2) EP1005342B1 (fr)
JP (1) JP3739802B2 (fr)
KR (2) KR100426657B1 (fr)
CN (2) CN1158074C (fr)
AP (1) AP1103A (fr)
AR (1) AR057242A2 (fr)
AT (2) ATE281166T1 (fr)
AU (1) AU740022B2 (fr)
BG (2) BG109365A (fr)
BR (1) BR9808722A (fr)
CA (2) CA2288003C (fr)
CZ (2) CZ298270B6 (fr)
DE (2) DE69809928T2 (fr)
DK (2) DK1222921T3 (fr)
EA (2) EA002920B1 (fr)
EE (1) EE04870B1 (fr)
ES (2) ES2232687T3 (fr)
GE (1) GEP20032970B (fr)
HK (1) HK1025907A1 (fr)
HU (1) HU229641B1 (fr)
IL (2) IL155799A (fr)
IS (1) IS2087B (fr)
LV (1) LV12492B (fr)
ME (1) ME00530B (fr)
NO (2) NO313983B1 (fr)
NZ (2) NZ500149A (fr)
OA (1) OA11169A (fr)
PL (1) PL193275B1 (fr)
PT (2) PT1222921E (fr)
RO (1) RO120605B1 (fr)
SI (1) SI20149B (fr)
SK (2) SK283947B6 (fr)
TR (1) TR199902733T2 (fr)
UA (2) UA57079C2 (fr)
WO (1) WO1998050035A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (fr) 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
ZA200806310B (en) 2006-01-09 2009-12-30 Romark Lab Lc Viral hepatitis treatment
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
SG10201402281WA (en) 2009-05-12 2014-07-30 Romark Lab Lc Haloalkyl heteroaryl benzamide compounds
BRPI1014322A2 (pt) 2009-06-26 2015-08-25 Romark Lab Lc Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica.
BR112014018149B1 (pt) 2012-01-27 2020-09-29 Siegfried Rhein S.A. De C.V Composição farmacêutica de nitazoxanida
JP6633092B2 (ja) * 2014-11-11 2020-01-22 ロマーク ラボラトリーズ，リミティド カンパニー チゾキサニド、その類似体又は塩のプロドラッグを用いる組成物及び治療方法
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
CA3176134A1 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions heterodimeres et methodes pour le traitement de troubles oculaires
WO2022130406A1 (fr) * 2020-12-15 2022-06-23 Cipla Limited Composition pour inhalation composée de nitazoxanide ou de ses dérivés s'utilisant dans le traitement d'une maladie à coronavirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen

Also Published As

Publication number Publication date
DK1005342T3 (da) 2003-03-24
TR199902733T2 (xx) 2000-03-21
AR057242A2 (es) 2007-11-21
NO335781B1 (no) 2015-02-16
NO995406D0 (no) 1999-11-04
DE69809928D1 (de) 2003-01-16
AP9901675A0 (en) 1999-12-31
CA2418634C (fr) 2004-10-26
BR9808722A (pt) 2000-07-11
NO20021832D0 (no) 2002-04-18
BG109365A (en) 2006-08-31
EA002920B1 (ru) 2002-10-31
PL193275B1 (pl) 2007-01-31
KR20040004544A (ko) 2004-01-13
CN1158074C (zh) 2004-07-21
HK1025907A1 (en) 2000-12-01
UA74388C2 (uk) 2005-12-15
EP1222921A1 (fr) 2002-07-17
HUP0003330A3 (en) 2002-10-28
IL155799A (en) 2004-08-31
DE69827417T2 (de) 2005-10-27
OA11169A (en) 2003-04-25
PL336805A1 (en) 2000-07-17
BG103958A (en) 2000-07-31
EE9900578A (et) 2000-08-15
ES2150404T1 (es) 2000-12-01
BG64973B1 (bg) 2006-11-30
ATE281166T1 (de) 2004-11-15
RO120605B1 (ro) 2006-05-30
NO995406L (no) 2000-01-04
CN100515420C (zh) 2009-07-22
IL132516A0 (en) 2001-03-19
CZ298269B6 (cs) 2007-08-08
EP1005342B1 (fr) 2002-12-04
ES2150404T3 (es) 2003-07-01
ME00530B (me) 2011-10-10
GEP20032970B (en) 2003-05-27
NO313983B1 (no) 2003-01-13
EA200100956A1 (ru) 2002-02-28
JP3739802B2 (ja) 2006-01-25
WO1998050035A1 (fr) 1998-11-12
LV12492B (en) 2001-01-20
DE69809928T2 (de) 2003-04-24
LV12492A (en) 2000-06-20
SK283947B6 (sk) 2004-05-04
SK283946B6 (sk) 2004-05-04
JP2001503067A (ja) 2001-03-06
IL155799A0 (en) 2003-12-23
AP1103A (en) 2002-09-04
IS5223A (is) 1999-10-19
CA2288003C (fr) 2003-10-21
KR100426657B1 (ko) 2004-04-13
IS2087B (is) 2006-03-15
KR100576646B1 (ko) 2006-05-08
SI20149B (en) 2001-08-31
EA199901012A1 (ru) 2000-08-28
CZ391199A3 (cs) 2000-07-12
NO20021832L (no) 2000-01-04
AU7289598A (en) 1998-11-27
SK151199A3 (en) 2000-07-11
IL132516A (en) 2003-12-10
DE69827417D1 (de) 2004-12-09
PT1005342E (pt) 2003-02-28
UA57079C2 (uk) 2003-06-16
NZ513881A (en) 2002-10-25
DK1222921T3 (da) 2005-03-07
EA002908B1 (ru) 2002-10-31
EP1005342A4 (fr) 2001-02-07
ATE228839T1 (de) 2002-12-15
EP1005342A1 (fr) 2000-06-07
EP1222921B1 (fr) 2004-11-03
CN1255060A (zh) 2000-05-31
SI20149A (sl) 2000-08-31
CA2418634A1 (fr) 1998-11-12
CN1552322A (zh) 2004-12-08
ES2232687T3 (es) 2005-06-01
HU229641B1 (en) 2014-03-28
HUP0003330A2 (hu) 2001-05-28
PT1222921E (pt) 2005-02-28
AU740022B2 (en) 2001-10-25
NZ500149A (en) 2001-11-30
KR20010020322A (ko) 2001-03-15
CA2288003A1 (fr) 1998-11-12
CZ298270B6 (cs) 2007-08-08

Similar Documents

Publication Publication Date Title
BR9706311A (pt) Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética
BR9802130A (pt) Compostos triaromáticos composição farmacêutica composição cosmética e uso de uma composição cosmética
PT907364E (pt) Composicao farmaceutica de libertacao sustida
BR9707501A (pt) Composto composição farmacêutica e uso do composto
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
HUP0004096A3 (en) Aggregates of human insulin derivatives and pharmaceutical compositions comprising thereof
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
BR9707808A (pt) Composto composição farmacêutica e uso do composto
EE9900578A (et) Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid
BR9509688A (pt) Composto e composição farmacêutica
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
BR9505130A (pt) Composto e composiçao farmacêutica
DE69830929D1 (de) N-hydroxyurea-derivat und dieses enthaltende pharmazeutische zusammensetzung
BR1100391A (pt) Composto e composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use
ID23048A (id) Komposisi farmasi protein hedgehog dan penggunaanny a
BR1100838A (pt) Composto e composição farmacêutica
BR9500539A (pt) Composto farmacêutico e composição farmacêutica
FI955718A (fi) Vehnänorasuutetta sisältävä kosmeettinen ja farmaseuttinen koostumus
ID22356A (id) Komposisi farmasi protein hedgehog serta pemakaiannya
IL157078A0 (en) Compounds and pharmaceutical compositions for the inhibition of the expression of vcam-1

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231